The Bodine Journal highlights the research covered by the Department of Radiation Oncology at Jefferson Medical College of Thomas Jefferson University. It is my pleasure to show the depth and breadth of our organization and the talent of our staff and faculty. We welcome any comments and suggestions.
Current Issue: Volume 3, Issue 1 (2010) Fall 2010
https://doi.org/10.29046/TBJ.003.1
Accepted Abstracts
Functional Antagonism Between Vorinostat and Temozolomide when Combined with Ionizing Radiation (IR) in Glioblastoma
Y. R. Lawrence, Y. Liu, B. Andersen, X. Xia, A. P. Dicker, and P. Wachsberger
Effects of EGFR Expression on Anti-tumor Efficacy of Vandetanib or Cediranib Combined with Radiotherapy (RT) in U87 Human Glioblastoma (GBM) Xenografts
P. Wachsberger, Y. R. Lawrence, Y. Liu, and A. P. Dicker
Control of Glycolytic Flux by AMPK and p53-Mediated Signaling Pathways in Tumor Cells Adapted to Grow at Low pH
E. E. Mendoza, J. Caro, D. B. Leeper, and R. Burd
Potential for Thermal Enhancement by Quercetin Mediated Mechanisms Targeting p53 Antagonists in Human Melanoma Cells
T. Thangasamy, K. Limesand, D. B. Leeper, and R. Burd
Acute Neurological Toxicity (NT) and Long-Term Outcomes in High-grade Glioma RTOG Trials
Y. R. Lawrence, M. Wang, A. P. Dicker, D. W. Andrews, W. J. Curran, J. M. Michalski, L. Souhami, W. A. Yung, and M. Mehta
Combination of Vorinostat with Whole-brain Radiotherapy in the Treatment of Brain Metastases
Y. R. Lawrence, R. M. Pfeffer, M. Werner-Wasik, H. Choy, and A. Dicker
Accuracy of Cancer Information on the Internet: A Comparison of a Wiki with a Professionally Maintained Database
M. S. Rajagopalan, V. Khanna, M. Stott, Y. Leiter, T. N. Showalter, A. Dicker, and Y. L. Lawrence
Dosimetric Advantages of Active Tracking and Dynamic Dose Delivery
I. Buzurovic, K. Huang, M. Werner-Wasik, T. Biswas, J. M. Galvin, A. Dicker, Y. Yu, and T. Podder
Motion Control Consistency with Abdominal Compression Device from Daily 4D CBCT
Y. Cui, A. S. Harrison, and Y. Xiao
Optical Guidance System vs. CBCT for Phantom and Patient Setup
L. Fu, H. Perera, H. Liu, Y. Xiao, and Y. Yu
Performance Study of Novel Accelerationenhanced Filters in the Prediction of Normal and Irregular Respiration Motion
K. Huang, I. Buzurovic, M. Werner-Wasik, T. Biswas, A. Dicker, J. Galvin, Y. Yu, and T. Podder
Feasibility of Improving Cone Beam CT Number Consistency with a Scatter-Correction Algorithm
J. Li, W. Yao, Y. Xiao, and Y. Yu
Predictors of Survival for Patients with Non-small Cell Lung Cancer and Synchronous Brain Metastases with FDG-PET/CT Staging
N. Ohri, Y. Xiao, and M. Werner-Wasik
Comparison of a Novel Curvilinear Approach to Conventional Rectilinear Approach for Prostate Seed Implant
T. K. Podder, A. P. Dicker, and Y. Yu
IMRT for Craniospinal Irradiation: A Dosimetric Comparison
M. Studenski, T. Biswas, Y. Xiao, and A. Harrison
Measuring Pacemaker Dose: A Clinical Perspective
M. Studenski, Y. Xiao, and A. Harrison
A Procedure for Standardizing MLC Quality Assurance for Elekta Linac
K. Yan, M. Studenski, H. Liu, I. Buzurovic, Y. Cui, L. Shabason, A. Harrison, Y. Yu, M. Hossain, and Y. Xiao
Control of Glycolytic Flux by AMPK and p53-mediated Signaling Pathways in Tumor Cells Grown at Low pH
D. B. Leeper, E. E. Mendoza, J. Caro, and R. Burd
Effect of Cediranib, Temozolamide and Radiotherapy in U87 GBM wtEGFR and EGFRvIII-expressing Xenografts
P. Wachsberger; R. Y, Lawrence; Y. Liu; B. Andersen; and A. P. Dicker
Results of a Phase I Trial of Induction Cisplatin, Docetaxel, 5-FU and Erlotinib Followed by Cisplatin, Bevacizumab and Erlotinib with Radiotherapy for Advanced Head and Neck Cancer
P. H. Ahn, M. Machtay, P. R. Anné, E. Wuthrick, W. M. Keane, D. Cognetti, A. P. Dicker, and R. S. Axelrod
Time Interval Between Staging FDG Positron Emission Tomography (PET) and Initiation of Stereotactic Lung Radiotherapy (SBRT) Impacts the Risk of Recurrence and Metastasis in Non-small Cell Lung Cancer (NSCLC)
B. Belderbos, A. Hope, L. L. Kestin, M. Guckenberger, M. Werner-Wasik, J. J. Sonke, J. P. Bissonnette, Y. Xiao, D. Yan, and I. S. Grills
Dosimetric Evaluation of Tumor Tracking in 4D Radiotherapy
I. Buzurovic, M. Werner-Wasik, T. Biswas, J. Galvin, A. Dicker, Y. Yu, and T. Podder
Decrease of Morbidity and Cost of Care with Prophylactic Cranial Irradiation for Non-small Cell Lung Cancer
C. E. Champ, N. Ohri, and M. Werner-Wasik
Uncertainty and Margin Study for IMRT, VMAT, and Proton Beam Therapy for Treatment After Radical Prostatectomy
Y. Cui, A. S. Harrison, M T. Studenski, T. N. Showalter, J. O. Deasy, Y. Yu, J. M. Galvin, and Y. Xiao
Should Hypopharynx Cancer Continue to be Included in “Multi-Head and Neck” Trials within the RTOG?
R. Den, Q. Zhang, D. Cognetti, M. Machtay, J. S. Cooper, A. S. Garden, C. U. Jones, S. Yom, and K. K. Ang
Dosimetric Comparison of VMAT, IMRT and Proton Therapy for Post- Prostatectomy Radiation Therapy for Prostate Cancer
L. A. Doyle, M. Studenski, A. Harvey, A. P. Dicker, Y. Xiao, Y. Yu, T. N. Showalter, and A. Harrison
IGRT After Prostatectomy: Evaluation of Corrective Shifts and Toxicity Using Online Cone Beam CT vs. Weekly Port Films for Target Localization
H. B. Eldredge, M. Studenski, S. Keith, E. J. Trabulsi, A. Harvey, C. Lallas, L. Gomella, A. P. Dicker, and T. N. Showalter
Pathologic Correlation of PET-CT Based Auto Contouring for Radiation Planning in Lung Cancer
S. E. Fogh, A. Farach, C. Intenzo, R. Axelrod, P. McCue, A. Harper, A. Nelson, and M Werner-Wasik
Toxicity of Phase I Radiation Oncology Trials: Worldwide Experience
C. Glass, R. B. Den, A. P. Dicker, and Y. R. Lawrence
A Multi-national Pooled Analysis of 434 Cases of Stage I Non-small Cell Lung Cancer (NSCLC) Treated with Volumetrically Image-guided Stereotactic Lung Radiotherapy: Results from the Elekta Collaborative Lung Research Group
I. S. Grills, A. J. Hope, M. Guckenberger, L. L. Kestin, M. Werner-Wasik, D. Yan, J. J. Sonke, J. P. Bissonnette, Y. Xiao, and J. Belderbos
Poor Pulmonary Function is Not Associated with Increased Rates of Toxicity or Decreased Overall Survival After Stereotactic Body Radiotherapy for Early Stage Non-Small Cell Lung Cancer: Results of a Multi-institutional Analysis
M. Guckenberger, J. Belderbos, A. Hope, L. L. Kestin, M. Werner-Wasik, J. J. Sonke, Y. Xiao, D. Yan, J. Wilbert, and I. S. Grills
Substantial Dose-response Relationship with Clinical Outcome for Lung Stereotactic Body Radiotherapy (SBRT) Delivered via Online Image Guidance
L. Kestin, I. Grills, M. Guckenberger, J. Belderbos, A. J. Hope, M. Werner-Wasik, J. J. Sonke, J. P. Bissonnette, Y. Xiao, and D. Yan
Early Stage Testicular Seminoma: A Multicenter Review of Treatment Outcomes and Patterns of Recurrence
M. Kim, E. Wuthrick, and A. Lin
Evolving Role of Vorinostat Combined with Radiation Therapy in the Treatment of Brain Tumors, from the Lab to the Clinic
Y. R. Lawrence, P. Wachsberger, Y. Liu, B. Andersen, and A. P. Dicker
Prophylactic Radiation Therapy is Safe and Effective Treatment for the Prevention of Recurrent Heterotopic Ossification in Elbow and Knee Joints
M. V. Mishra, L. Austin, J. Parvisi, M. Ramsey, and T. N. Showalter
Reirradiation for Recurrent Meningioma
N. Ohri, A. Wojcieszynski, J. J. Evans, D. W. Andrews, and M. Werner-Wasik
MIRAB: An Image-Guided Multichannel Robot for Prostate Brachytherapy
T. Podder, I. Buzurovic, K. Huang, and Y. Yu
Intensity Modulated Radiation Therapy Compared with 3D Conformal Radiotherapy for Craniospinal Irradiation in Adults – Do We Gain Anything?
X. Shen, M. Studenski, A. Harrison, Y. Xiao, and T. Biswas
Costs of Early Adjuvant Radiation Therapy After Radical Prostatectomy: A Decision Analysis
T. N. Showalter, K. A. Foley, E. Jutkowitz, C. Lallas, A. J. Harvey, E. J. Trabulsi, L. G. Gomella, A. P. Dicker, and L. T. Pizzi
Potential for Dose-escalation in the Post-prostatectomy Setting with Intensitymodulated Radiation Therapy: A Dosimetric Study Using EORTC Consensus Guidelines for Target Volume Contours
M. Studenski, A. Harrison, S. Anamalayil, A. Harvey, E. Trabulsi, Y. Xiao, Y. Yu, A. P. Dicker, and T. N. Showalter
Chart Rounds in the Digital Age: A Survey of North American Institutions
M. A. Whiton, A. P. Dicker, E. J. Wuthrick, L. Doyle, A. S. Harrison, and Y. R. Lawrence
The GUCY2C Tumor Suppressor is the Nexus of a Paracrine Hormone Axis Preventing Radiotherapy-Induced Gastrointestinal (GI) Toxicity
E. J. Wuthrick, P. Li, J. E. Lin, A. P. Dicker, D. Leeper, and S. A. Waldman
Departmental Information
Research Study
Support Group
